Abstract
AMD is a leading cause of irreversible vision loss in people over 60 years of age. Although the pathogenesis of this disease is multifactorial, clinical studies have revealed that oxidative damage is a significant etiological factor. The ubiquitin proteolytic system (UPS) plays a major cytoprotective role in the retina. It accomplishes this largely by degrading oxidatively-damaged proteins to prevent their toxic accumulation. In this review, we discuss numerous features of the UPS in the retina and propose various ways that components of the UPS can be harnessed for therapeutic intervention in AMD. We discuss published work describing the distribution of various UPS enzymes in different retinal cell types and present new findings describing the localization of the class III ubiquitin conjugating enzymes. These enzymes are functional homologues of a pair of yeast enzymes that mediate the degradation of misfolded and oxidatively-damaged proteins. We also discuss recent work showing that only newly synthesized proteins which have incurred oxidative damage are targeted for degradation by the UPS whereas the turnover of oxidatively-damaged, long-lived proteins is largely unchanged. Additionally, we review recent work describing how polyubiquitylation influences the sorting of damaged proteins into one of two novel intracellular compartments. Finally, we discuss how the UPS modulates the stability and activity of Nrf2, the major anti-oxidant transcription factor in the retina.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
AREDS (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8. Arch Ophthalmol 119:1417–1436
Benolken RM, Anderson RE, Wheeler TG (1973) Membrane fatty acids associated with the electrical response in visual excitation. Science 182:1253–1254
Bonfanti L, Candeo P, Piccinini M et al (1992) Distribution of protein gene product 9.5 (PGP 9.5) in the vertebrate retina: evidence that immunoreactivity is restricted to mammalian horizontal and ganglion cells. J Comp Neurol 322:35–44
Bosu DR, Kipreos ET (2008) Cullin-RING ubiquitin ligases: global regulation and activation cycles. Cell Div 3:7
Crabb JW, Miyagi M, Gu X et al (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 99:14682–14687
Dinkova-Kostova AT, Holtzclaw WD, Cole RN et al (2002) Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A 99:11908–11913
Dudek EJ, Shang F, Valverde P et al (2005) Selectivity of the ubiquitin pathway for oxidatively modified proteins: relevance to protein precipitation diseases. FASEB J 19:1707–1709
Eggler AL, Luo Y, van Breemen RB et al (2007) Identification of the highly reactive cysteine 151 in the chemopreventive agent-sensor Keap1 protein is method-dependent. Chem Res Toxicol 20:1878–1884
Ehrlich R, Harris A, Kheradiya NS et al (2008) Age-related macular degeneration and the aging eye. Clin Interv Aging 3:473–482
Fang S, Weissman AM (2004) A field guide to ubiquitylation. Cell Mol Life Sci 61:1546–1561
Gao X, Talalay P (2004) Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage. Proc Natl Acad Sci U S A 101:10446–10451
Gu X, Meer SG, Miyagi M et al (2003) Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem 278:42027–42035
Hollyfield JG, Bonilha VL, Rayborn ME et al (2008) Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 14:194–198
Kaganovich D, Kopito R, Frydman J (2008) Misfolded proteins partition between two distinct quality control compartments. Nature 454:1088–1095
Kobayashi A, Kang MI, Okawa H et al (2004) Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 24:7130–7139
Kong L, Tanito M, Hung Z et al (2007) Delay of photoreceptor degeneration in tubby mouse by sulforaphane. J Neurochem 101(4):1041–1052
Levonen AL, Landar A, Ramachandran A et al (2004) Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem J 378:373–382
Li W, Kong AN (2009) Molecular mechanisms of Nrf2-mediated antioxidant response. Mol Carcinog 48:91–104
Matuschewski K, Hauser HP, Treier M et al (1996) Identification of a novel family of ubiquitin-conjugating enzymes with distinct amino-terminal extensions. J Biol Chem 271:2789–2794
Medicherla B, Goldberg AL (2008) Heat shock and oxygen radicals stimulate ubiquitin-dependent degradation mainly of newly synthesized proteins. J Cell Biol 182:663–673
Nguyen T, Sherratt PJ, Huang HC et al (2003) Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J Biol Chem 278:4536–4541
Nowak JZ (2006) Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep 58:353–363
Obin MS, Jahngen-Hodge J, Nowell T et al (1996) Ubiquitinylation and ubiquitin-dependent proteolysis in vertebrate photoreceptors (rod outer segments). Evidence for ubiquitinylation of Gt and rhodopsin. J Biol Chem 271:14473–14484
Ross CA, Pickart CM (2004) The ubiquitin-proteasome pathway in Parkinson’s disease and other neurodegenerative diseases. Trends Cell Biol 14:703–711
Sano Y, Furuta A, Setsuie R et al (2006) Photoreceptor cell apoptosis in the retinal degeneration of Uchl3-deficient mice. Am J Pathol 169:132–141
Sas K, Robotka H, Toldi J et al (2007) Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 257:221–239
Shang F, Nowell TR Jr, Taylor A (2001) Removal of oxidatively damaged proteins from lens cells by the ubiquitin-proteasome pathway. Exp Eye Res 73:229–238
Tanito M, Masutani H, Kim YC, Nishikawa M, Ohira A, Yodoi J (2005) Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice. Invest Ophthalmol Vis Sci 46(3):979–987
Yamamoto T, Suzuki T, Kobayashi A et al (2008) Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol Cell Biol 28:2758–2770
Zhang DD, Hannink M (2003) Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 23:8137–8151
Zhang DD, Lo SC, Cross JV et al (2004) Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol 24:10941–10953
Zhang Y, Talalay P, Cho CG et al (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci U S A 89:2399–2403
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Plafker, S.M. (2010). Oxidative Stress and the Ubiquitin Proteolytic System in Age-Related Macular Degeneration. In: Anderson, R., Hollyfield, J., LaVail, M. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 664. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1399-9_51
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1399-9_51
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1398-2
Online ISBN: 978-1-4419-1399-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)